Clear cell renal cell carcinoma (ccRCC) is an aggressive malignancy with limited treatment options and high rates of resistance to first-line kinase inhibitors. Current therapies largely target the ...
Immune checkpoint inhibitors have transformed cancer therapy. However, only a fraction of patients benefit from these treatments. The variability in patient responses remains a significant challenge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results